Ownership history in Red Tortoise LLC · 14 quarters on record
This page tracks every 13F SEC filing in which Red Tortoise LLC reported a position in ENLIVEX THERAPEUTICS LTD COM (ENLV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 150 | — | 0% | 0.00% | $105 | $0.70 |
| 2025 Q3 | UNCHANGED | 150 | — | 0% | 0.00% | $156 | $1.04 |
| 2025 Q2 | UNCHANGED | 150 | — | 0% | 0.00% | $168 | $1.12 |
| 2025 Q1 | UNCHANGED | 150 | — | 0% | 0.00% | $146 | $0.97 |
| 2024 Q4 | UNCHANGED | 150 | — | 0% | 0.00% | $176 | $1.17 |
| 2024 Q3 | UNCHANGED | 150 | — | 0% | 0.00% | $252 | $1.68 |
| 2024 Q2 | UNCHANGED | 150 | — | 0% | 0.00% | $213 | $1.42 |
| 2024 Q1 | UNCHANGED | 150 | — | 0% | 0.00% | $569 | $3.79 |
| 2023 Q4 | UNCHANGED | 150 | — | 0% | 0.00% | $405 | $2.70 |
| 2023 Q3 | UNCHANGED | 150 | — | 0% | 0.00% | $237 | $1.58 |
As of 2025 Q4 — sorted by position size